We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Mepolizumab reduced the risk for a first severe ...

Adding mepolizumab to inhaled triple therapy significantly improved exacerbation outcomes compared with placebo in adults with chronic obstructive pulmonary disease (COPD), based on data from the ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Leah J. Witt, MD: ...

Among patients with chronic obstructive pulmonary disease (COPD) and severe chronic breathlessness, short-term daily treatment with low doses of extended-release morphine did not significantly reduce ...

Please provide your email address to receive an email when new articles are posted on . Patients with COPD report more depressive symptoms vs. patients without COPD. There may be a bidirectional ...

Increased breathlessness was most strongly associated with obesity (aOR, 7.6), stress (aOR, 6.7), heart failure (aOR, 6.1), and chronic bronchitis (aOR, 4.2). Breathlessness in middle-aged adults is ...

Morphine failed to improve chronic breathlessness from cardiorespiratory conditions in one randomized trial, but online group singing exercises did boost quality of life in another. In the MABEL trial ...